Harish Shantharam

Insider Reports History

Location
Newark, CA
Signature
/s/ Shelly Pinto, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harish Shantharam:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALX ONCOLOGY HOLDINGS INC Chief Financial Officer Common Stock 75,000 $58,402 $0.7787 18 Aug 2025 Direct
CymaBay Therapeutics, Inc. Chief Financial Officer Common Stock 0 $0 $2.94 22 Mar 2024 Direct
ALX ONCOLOGY HOLDINGS INC Chief Financial Officer Employee Stock Option (right to buy) 198,750 14 Oct 2025 Direct
CymaBay Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Harish Shantharam

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALXO ALX ONCOLOGY HOLDINGS INC 14 Oct 2025 1 $0 4 Chief Financial Officer 16 Oct 2025, 16:01
ALXO ALX ONCOLOGY HOLDINGS INC 18 Aug 2025 1 +$58,402 4 Chief Financial Officer 20 Aug 2025, 16:02
ALXO ALX ONCOLOGY HOLDINGS INC 11 Apr 2025 1 $0 4 Chief Financial Officer 15 Apr 2025, 16:16
ALXO ALX ONCOLOGY HOLDINGS INC 21 Jan 2025 1 $0 4 Chief Financial Officer 23 Jan 2025, 18:19
ALXO ALX ONCOLOGY HOLDINGS INC 21 Jan 2025 0 $0 3 Chief Financial Officer 23 Jan 2025, 18:17
/report/000095017024035460-shantharam-harish-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 3 $0 4 Chief Financial Officer 22 Mar 2024, 17:03
/report/000106299324001435-shantharam-harish-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 2 $0 4 Chief Financial Officer 26 Jan 2024, 18:33
/report/000106299323011932-shantharam-harish-2023-05-22 CymaBay Therapeutics, Inc. 22 May 2023 1 $0 4 Chief Financial Officer 22 May 2023, 17:13
/report/000106299323011931-shantharam-harish-2023-05-22 CymaBay Therapeutics, Inc. 22 May 2023 0 $0 3 Chief Financial Officer 22 May 2023, 17:06